Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinwang Duan

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Arthritis Research & Therapy|December 28, 2024
Risk prediction of new-onset thrombocytopenia in patients with systemic lupus erythematosus: a multicenter prospective cohort study based on Chinese SLE treatment and research group (CSTAR) registryYupei Zhang, Nan Jiang, Xinwang Duan, et al.
Rheumatology and Therapy|February 13, 2024
Anemia and Low Body Mass Index in Axial Spondyloarthritis: Results from ChinaSpA, the Chinese Spondyloarthritis RegistryHailong Li, Qingyang Li, Xinwang Duan, et al.
Patient Preference and Adherence|July 2, 2020
Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in ChinaNan Jiang, Pingting Yang, Shengyun Liu, et al.
Rheumatology (Oxford, England)|July 11, 2025
Validation and clinical application of 2022 ACR/EULAR criteria for Takayasu arteritis in a large Chinese cohortJinwei Gao, Shiping He, Yao Liu, et al.
International Journal of Rheumatic Diseases|October 9, 2020
Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow-ups and predictors of achieving treatment targetYirong Xiang, Qian Wang, Hongbin Li, et al.
Arthritis Research & Therapy|November 17, 2017
Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritisShangyi Jin, Mengtao Li, Yongfei Fang, et al.
Arthritis Research & Therapy|February 11, 2025
The conditions that patients with systemic lupus erythematosus should fulfill before pregnancy to optimize outcomes: a large-scale multicenter cohort study from ChinaXueyang Zhang, Lingshan Liu, Shudian Lin, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Real-world therapeutic performance of pirfenidone for connective tissue disease-associated interstitial lung diseasesXueting Yuan, Chen Yu, Shengyun Liu, et al.
Lupus Science & Medicine|January 4, 2022
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort studyNan Jiang, Mengtao Li, Hongfeng Zhang, et al.
Clinical Rheumatology|March 9, 2020
Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional studyYuying Zhang, Mengtao Li, Liyun Zhang, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Arthritis Research & Therapy|December 28, 2024
Risk prediction of new-onset thrombocytopenia in patients with systemic lupus erythematosus: a multicenter prospective cohort study based on Chinese SLE treatment and research group (CSTAR) registryYupei Zhang, Nan Jiang, Xinwang Duan, et al.
Rheumatology and Therapy|February 13, 2024
Anemia and Low Body Mass Index in Axial Spondyloarthritis: Results from ChinaSpA, the Chinese Spondyloarthritis RegistryHailong Li, Qingyang Li, Xinwang Duan, et al.
Patient Preference and Adherence|July 2, 2020
Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in ChinaNan Jiang, Pingting Yang, Shengyun Liu, et al.
Rheumatology (Oxford, England)|July 11, 2025
Validation and clinical application of 2022 ACR/EULAR criteria for Takayasu arteritis in a large Chinese cohortJinwei Gao, Shiping He, Yao Liu, et al.
International Journal of Rheumatic Diseases|October 9, 2020
Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow-ups and predictors of achieving treatment targetYirong Xiang, Qian Wang, Hongbin Li, et al.
Arthritis Research & Therapy|November 17, 2017
Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritisShangyi Jin, Mengtao Li, Yongfei Fang, et al.
Arthritis Research & Therapy|February 11, 2025
The conditions that patients with systemic lupus erythematosus should fulfill before pregnancy to optimize outcomes: a large-scale multicenter cohort study from ChinaXueyang Zhang, Lingshan Liu, Shudian Lin, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Real-world therapeutic performance of pirfenidone for connective tissue disease-associated interstitial lung diseasesXueting Yuan, Chen Yu, Shengyun Liu, et al.
Lupus Science & Medicine|January 4, 2022
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort studyNan Jiang, Mengtao Li, Hongfeng Zhang, et al.
Clinical Rheumatology|March 9, 2020
Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional studyYuying Zhang, Mengtao Li, Liyun Zhang, et al.
Pageof 8